Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
36.65
+0.95 (2.66%)
Jul 16, 2025, 2:59 PM CST

Orient Pharma Company Description

Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.

The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson’s and Alzheimer’s diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder.

It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and micro granules.

The company was founded in 2008 and is based in Taipei, Taiwan.

Orient Pharma Co., Ltd.
CountryTaiwan
Founded2008
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees173
CEOChun-Tong Huang

Contact Details

Address:
No. 368, Fu Hsing South Road
Taipei, 106
Taiwan
Phone886 2 2325 7621
Websiteoppharma.com

Stock Details

Ticker Symbol4166
ExchangeTaipei Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyTWD
ISIN NumberTW0004166004
SIC Code2834

Key Executives

NamePosition
Chun-Tong HuangGeneral Manager
Yi Xin ZhangChief Financial Officer
Zhi Cheng LuChief Operating Officer
Calvin TsaiGM and Director